Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Cyclosporine IP 0.5mg + Benzalkonium Chloride Solution IP 0.02% v/v Eye Drop
Therapeutic Category
Ophthalmology
Dosage Form
Eye Drops
Packaging Type
Dropper
Packaging
3ml
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Cyclonip Eye Drop (Cyclosporine 0.5mg + Benzalkonium Chloride) is a premium, high-profit chronic care product built for our PCD Pharma Franchise partners.
Cyclosporine is the gold standard for treating chronic dry eye disease by managing the underlying inflammation. Since dry eye often requires lifelong treatment, this product guarantees stable, recurring revenue and maximum long-term patient value.
Why Cyclonip is Your Key to Profit:
Guaranteed Recurring Revenue: As a long-term maintenance drug, Cyclosporine ensures consistent, year-round refills, providing superior financial stability compared to acute treatments.
Maximum Specialty Margin: Positioned in the highest value ophthalmic segment, this product commands premium pricing and secures some of the highest profit margins in the specialty eye care niche.
Specialist Loyalty: The clinical necessity of Cyclosporine for moderate-to-severe dry eye builds strong, reliable prescription loyalty from leading ophthalmologists and dry eye specialists.
Monopoly Opportunity: We offer exclusive rights for your area—meaning zero competition for this specific, high-demand formulation. Partner with us for full marketing support to secure high-value, recurring prescriptions and guaranteed business growth.
Contact us today to capture this max-margin chronic care segment!
The eye drop is generally well-tolerated. Mild side effects may include temporary stinging, burning, or slight redness upon application. Rarely, allergic reactions such as itching, swelling, or increased irritation may occur. Discontinue use and consult a healthcare professional if severe reactions develop.
Lubicom Ultra Eye Drop is indicated for relief from dry eyes, irritation, and oxidative stress-related ocular discomfort. It helps in lubricating the eyes, protecting against free radical damage, and improving overall eye health. It may also support visual clarity and reduce age-related oxidative changes in the eyes.
Use Lubicom Ultra Eye Drop exactly as directed. Avoid touching the dropper tip to the eye or any surface to prevent contamination. Remove contact lenses before application and wait at least 15 minutes before reinserting them. This product is for ocular use only and should not be swallowed.
Store Lubicom Ultra Eye Drop in a cool, dry place below 25°C, protected from direct sunlight. Keep the bottle tightly closed when not in use and out of reach of children. Discard any unused solution after the expiry date.
Composition : Torsemide 10mg Tablet
Composition : Torsemide 100mg Tablet
Composition : Torsemide 20 mg Tablet
Composition : Torsemide 40mg Tablet
Composition : Torsemide 5mg Tablet
Composition : Torsemide (10mg/ml) Injection
Composition : Torsemide 5 mg + Spironolactone 50 mg Tablet
Composition : TORSEMIDE 10 MG + SPIRONOLACTONE 25 MG
Composition : Torsemide 10mg + Spironolactone 50mg Tablets
Composition : Chlorthalidone 6.25mg Tablet
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Cyclosporine ophthalmic formulation has strong demand in the ophthalmology segment, making it a high-potential product for medical distributors, wholesalers, and pharma franchise partners looking to expand in the PCD pharma franchise market.
Medical distributors and wholesalers can benefit from consistent demand in dry eye syndrome, ocular inflammation, and long-term eye care therapies prescribed by ophthalmologists. It strengthens their ophthalmic and chronic eye care portfolio.
Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities for Cyclosporine I.P. 0.5mg + Benzalkonium Chloride Eye Drops with monopoly rights, promotional support, quality packaging, competitive pricing, and reliable supply support for distributors and medical agencies.
Wholesalers and medical agencies benefit from steady prescription-based demand from eye specialists, repeat usage in chronic therapy, and stable margins when partnering with Cafoli Lifecare.
Medical distributors, stockists, wholesalers, and pharma professionals interested in this ophthalmic formulation can contact Cafoli Lifecare to discuss PCD pharma franchise opportunities, bulk orders, pricing details, and distribution support services.